Molina Healthcare (NYSE:MOH)‘s stock had its “hold” rating reaffirmed by equities researchers at Jefferies Group in a research report issued to clients and investors on Wednesday. They currently have a $80.00 price objective on the stock. Jefferies Group’s price objective indicates a potential upside of 6.02% from the company’s current price.

A number of other research analysts have also weighed in on the company. Zacks Investment Research lowered Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 9th. Morgan Stanley reduced their price objective on Molina Healthcare from $97.00 to $94.00 and set an “overweight” rating for the company in a research report on Wednesday, February 7th. JPMorgan Chase & Co. raised Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 16th. Leerink Swann raised their price objective on Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. Finally, Goldman Sachs Group assumed coverage on Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price objective for the company. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $71.64.

Molina Healthcare (NYSE:MOH) opened at $75.46 on Wednesday. Molina Healthcare has a 52-week low of $42.56 and a 52-week high of $93.98. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $4,679.12, a P/E ratio of -8.37, a P/E/G ratio of 0.91 and a beta of 1.10.

In related news, Director John C. Molina sold 21,650 shares of Molina Healthcare stock in a transaction on Monday, January 29th. The stock was sold at an average price of $92.41, for a total value of $2,000,676.50. Following the completion of the sale, the director now owns 414,151 shares of the company’s stock, valued at $38,271,693.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John C. Molina sold 5,385 shares of Molina Healthcare stock in a transaction on Friday, January 26th. The stock was sold at an average price of $92.88, for a total value of $500,158.80. Following the completion of the sale, the director now directly owns 414,151 shares of the company’s stock, valued at approximately $38,466,344.88. The disclosure for this sale can be found here. In the last three months, insiders sold 703,705 shares of company stock valued at $56,003,375. Corporate insiders own 6.20% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC grew its holdings in shares of Molina Healthcare by 53.5% in the fourth quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after acquiring an additional 751,800 shares during the period. Jana Partners LLC grew its holdings in shares of Molina Healthcare by 52.5% in the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after acquiring an additional 731,992 shares during the period. Iridian Asset Management LLC CT bought a new stake in shares of Molina Healthcare in the fourth quarter worth $128,179,000. Victory Capital Management Inc. grew its holdings in shares of Molina Healthcare by 36.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock worth $121,953,000 after acquiring an additional 420,756 shares during the period. Finally, Tiedemann Wealth Management LLC grew its holdings in shares of Molina Healthcare by 7.8% in the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after acquiring an additional 103,775 shares during the period. 96.22% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Molina Healthcare’s (MOH) “Hold” Rating Reiterated at Jefferies Group” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2018/02/14/molina-healthcares-moh-hold-rating-reiterated-at-jefferies-group.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.